Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 11585
  • 11586
  • 11587
  • …
  • ›
  • »

2024-11-20

Bio-Path (BPTH) Could Find a Support Soon, Here′s Why You Should Buy the Stock Now

2024-11-20

BeWhere Holdings reports Q3 results

2024-11-20

Renalytix AI reports Q1 results

2024-11-20

SpaceX Stock: The Destiny Tech100 ETF Could Surge 100% Over the Next Year

2024-11-20

ELECOM USA: NESTOUT Launches New Gear: Fan and Whistle Light Now Available for Outdoor Adventures

2024-11-20

Forte Biosciences announces oversubscribed $53 million private placement

2024-11-20

Mullen Continues Commercial EV Adoption Across College Campuses; Announces New EV Orders From Leading California Universities

2024-11-20

Proton Motor Power Systems seeks to delist from AIM by the year-end

2024-11-20

Ximen Mining Corp.: Ximen Mining Corp Drilling Intersects 16.30 g/t Gold on McKinney Vein Extension at its 100% Owned Amelia Gold Property - Camp McKinney BC

2024-11-20

Sonoran Desert Copper Corporation Announces Private Placement Financing and New Chief Financial Officer

2024-11-20

Guardian Exploration Announces Issuance of Stock Options

2024-11-20

Aptevo Therapeutics: First Patient Dosed in Aptevo′s Ongoing RAINIER Trial Achieves 90% Reduction in Leukemic Blasts Within the First 30 Days of Treatment, Continues Overall Efficacy Trend Seen in Prior Mipletamig AML Studies

  • «
  • ‹
  • …
  • 11585
  • 11586
  • 11587
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies